By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Nivalis Therapeutics (Formerly Known As N30 Pharma) 

3122 Sterling Circle

Boulder  Colorado  80301  U.S.A.
Phone: 720-945-7700 Fax: n/a


SEARCH JOBS



Key Statistics


Email:
Ownership: Public

Web Site: Nivalis
Employees:
Symbol: NVLS
 









Company News
Nivalis (NVLS) Decimated as Cystic Fibrosis Drug Flops in Mid-Stage Study 11/29/2016 5:37:31 AM
5 Biotechs Under $10 With Massive Potential 9/6/2016 6:19:02 AM
Nivalis Therapeutics Announces First Patient Dosed In Second Phase II Study Of N91115 For Treatment Of Cystic Fibrosis 5/17/2016 8:12:28 AM
Nivalis Therapeutics Announces Appointment Of Paul Sekhri To Its Board Of Directors 3/2/2016 8:07:14 AM
Nivalis Therapeutics Announces First Patient Dosed In Phase II Study Of N91115 For Treatment Of Cystic Fibrosis 12/1/2015 7:22:08 AM
Nivalis Therapeutics Announces Positive Phase Ib Results For N91115 In Patients With Cystic Fibrosis And Plans To Initiate Phase II Trial 10/8/2015 12:57:17 PM
Nivalis Therapeutics To Present At Two Upcoming Investor Conferences 9/4/2015 7:20:35 AM
Nivalis Therapeutics Reports Financial Results For The Second Quarter 2015 8/4/2015 8:12:23 AM
Nivalis Therapeutics IPO Nets $88M 6/23/2015 6:16:17 AM
Nivalis Therapeutics Set to Debut Tomorrow at $14 Per Share 6/17/2015 6:27:40 AM
123
//-->